CSL - Gross Profit On Sales

Stock Price
97.84
Daily Change
-0.85 -0.86%
Monthly
-28.58%
Yearly
-60.10%
Q2 Forecast
96.11

CSL reported $4.46B in Gross Profit on Sales for its fiscal semester ending in December of 2025.





Gross Profit On Sales Change Date
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 190K 15.57M Sep/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
CSL USD 4.46B 2.71B Dec/2025
Curis USD 1.14M 8.86M Dec/2025
Esperion Therapeutics USD 140.59M 94.57M Dec/2025
Immunic 0 0 Mar/2025
Infinity Pharmaceuticals USD 231K 59K Jun/2023
Minerva Neurosciences -4.27M 26.79M Dec/2024
Sangamo BioSciences -2.39M 1.09M Jun/2024
TherapeuticsMD USD 234K 79K Jun/2024